Media coverage
21
Media coverage
Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Morningstar.com Country/Territory United States Date 10/06/22 URL https://www.morningstar.com/news/globe-newswire/8569762/1112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelx-risk-stratification-in-stage-1-to-3-diabetic-kidney-disease-patients Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Street Insider Country/Territory United States Date 10/06/22 URL https://www.streetinsider.com/Press+Releases/1%2C112+Patient+Study+Demonstrates+Clinical+Utility+and+Care+Benefits+of+KidneyIntelX%E2%84%A2%C2%A0Risk+Stratification+in+Stage+1+to+3+Diabetic+Kidney+Disease+Patients/20199902.html Persons Joji Tokita Title Renalytix (RENX) Says 1,112 Patient Study Demonstrates Clinical Utility, Care Benefits of KidneyIntelX Risk Stratification in Stage 1 to 3 DKD Patients Media name/outlet Street Insider Country/Territory United States Date 10/06/22 URL https://www.streetinsider.com/FDA/Renalytix+%28RENX%29+Says+1%2C112+Patient+Study+Demonstrates+Clinical+Utility%2C+Care+Benefits+of+KidneyIntelX+Risk+Stratification+in+Stage+1+to+3+DKD+Patients/20199947.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet ADVFN UK Country/Territory United Kingdom Date 10/06/22 URL https://uk.advfn.com/stock-market/NASDAQ/RNLX/share-news/1-112-Patient-Study-Demonstrates-Clinical-Utility/88338188 Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Yahoo! Canada Country/Territory Canada Date 10/06/22 URL https://ca.sports.yahoo.com/news/1-112-patient-study-demonstrates-110000866.html?src=rss Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Yahoo! Finance Country/Territory United States Date 10/06/22 URL https://finance.yahoo.com/news/1-112-patient-study-demonstrates-110000866.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet MarketScreener.com Country/Territory United States Date 10/06/22 URL https://www.marketscreener.com/quote/stock/RENALYTIX-PLC-109818492/news/1-112-Patient-Study-Demonstrates-Clinical-Utility-and-Care-Benefits-of-KidneyIntelX-trade-Risk-Stra-40691954/ Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX(TM) Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Stockwatch Country/Territory Canada Date 10/06/22 URL www.stockwatch.com/News/Item/U-z8569762-U!RNLX-20220610/U/RNLX Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet ADVFN US Country/Territory United States Date 10/06/22 URL https://www.advfn.com/p.php?pid=nmona&article=88338188 Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Crwe World Country/Territory United States Date 10/06/22 URL crweworld.com/article/news-provided-by-globenewswire/2415063/1112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelxrisk-stratification-in-stage-1-to-3-diabetic-kidney-disease-patients Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Market Newsdesk Country/Territory United States Date 10/06/22 URL https://www.marketnewsdesk.com/index.php/1112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelx-risk-stratification-in-stage-1-to-3-diabetic-kidney-disease-patients/ Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet Spoke.com Country/Territory United States Date 10/06/22 URL https://www.spoke.com/press_releases/62a32f8cecb2a7f6d8005747 Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet GlobeNewswire Country/Territory United States Date 10/06/22 URL https://www.globenewswire.com/news-release/2022/06/10/2460402/0/en/1-112-Patient-Study-Demonstrates-Clinical-Utility-and-Care-Benefits-of-KidneyIntelX-Risk-Stratification-in-Stage-1-to-3-Diabetic-Kidney-Disease-Patients.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk ... Media name/outlet KULR 8 Country/Territory United States Date 10/06/22 URL https://www.kulr8.com/news/money/1-112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelx-risk/article_b7442dd6-7450-50e9-a751-789b46d7cc29.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk ... Media name/outlet Kentucky New Era Country/Territory United States Date 10/06/22 URL https://www.kentuckynewera.com/technology/article_a1299d92-b8cb-5a92-95f9-db623b785545.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients; Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates incr Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 10/06/22 Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Media name/outlet Bluefield Daily Telegraph Country/Territory United States Date 10/06/22 URL https://www.bdtonline.com/news/nation_world/1-112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelx-risk/article_8a1f0518-0bfa-5221-83b9-c64a505fccd7.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Media name/outlet Kentuckytoday.com Country/Territory United States Date 10/06/22 URL https://www.kentuckytoday.com/news/business/1-112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelx-risk/article_a9f5fe70-258f-5980-a951-afe58875f56d.html Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet 96.7 WSHV Country/Territory United States Date 10/06/22 URL lifestyle.967wshv.com/story/46667982/1112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelxrisk-stratification-in-stage-1-to-3-diabetic-kidney-disease-patients Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet BizWire Express Country/Territory India Date 10/06/22 URL www.bizwireexpress.com/showstoryGNW.php?storyid=410863 Persons Joji Tokita Title 1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients Media name/outlet MidPlains - News Channel Nebraska Country/Territory United States Date 10/06/22 URL midplains.newschannelnebraska.com/story/46667982/1112-patient-study-demonstrates-clinical-utility-and-care-benefits-of-kidneyintelxrisk-stratification-in-stage-1-to-3-diabetic-kidney-disease-patients Persons Joji Tokita